- Report
- January 2026
- 192 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- February 2026
- 288 Pages
Global
From €5136EUR$5,850USD£4,443GBP
- Report
- June 2025
- 185 Pages
Global
From €3950EUR$4,500USD£3,418GBP
- Report
- January 2026
- 198 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- January 2026
- 189 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- January 2026
- 191 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- January 2026
- 198 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- February 2026
- 372 Pages
Global
From €5136EUR$5,850USD£4,443GBP
- Report
- February 2026
- 367 Pages
Global
From €5136EUR$5,850USD£4,443GBP
- Report
- February 2026
- 170 Pages
Global
From €5136EUR$5,850USD£4,443GBP
- Report
- February 2026
- 194 Pages
Global
From €5136EUR$5,850USD£4,443GBP
- Report
- February 2026
- 293 Pages
Global
From €5136EUR$5,850USD£4,443GBP
- Report
- September 2025
- 250 Pages
Global
From €3942EUR$4,490USD£3,410GBP
- Report
- September 2025
- 250 Pages
Global
From €3942EUR$4,490USD£3,410GBP
- Report
- July 2025
- 175 Pages
Global
From €3942EUR$4,490USD£3,410GBP
- Report
- April 2025
- 250 Pages
Global
From €3942EUR$4,490USD£3,410GBP
- Report
- March 2025
- 250 Pages
Global
From €3942EUR$4,490USD£3,410GBP
- Report
- February 2025
- 302 Pages
Global
From €4389EUR$5,000USD£3,798GBP
- Clinical Trials
- April 2025
- 90 Pages
Global
From €1756EUR$2,000USD£1,519GBP
- Report
- November 2025
- 183 Pages
Global
From €3950EUR$4,500USD£3,418GBP

The antimalarial market is a subset of the infectious diseases drugs market, which focuses on the treatment and prevention of malaria. Antimalarial drugs are used to treat and prevent the spread of the Plasmodium parasite, which is responsible for the disease. These drugs are typically administered orally, intravenously, or intramuscularly, depending on the severity of the infection. Common antimalarial drugs include chloroquine, artemisinin, and mefloquine.
In addition to antimalarial drugs, the market also includes insecticides, insect repellents, and other preventive measures. These products are used to reduce the risk of infection by controlling the mosquito population, which is the primary vector for the Plasmodium parasite.
Notable companies in the antimalarial market include GlaxoSmithKline, Sanofi, Novartis, and Merck. These companies produce a variety of antimalarial drugs, insecticides, and other preventive measures. Show Less Read more